Ilia Terova

Ilia Terova has a diverse work experience in the field of chemistry. From 1998 to 2002, Terova worked as a student at Worcester State College. Terova then joined Framatome as a Chemist from July 2002 to June 2003. Following that, Terova pursued a Ph.D. in Analytical Chemistry at the University of New Hampshire from September 2004 to April 2011.

After completing their education, Terova joined Johnson Matthey in July 2010 as an Analytical Scientist. They held various roles within the company, including Analytical Staff Scientist from July 2010 to December 2017 and Analytical Senior Scientist from July 2015 to May 2019.

Currently, Terova is working at Spero Therapeutics, where they started as a Senior Manager in Analytical Development in June 2019. They were then promoted to Associate Director in Analytical Development in January 2021 and currently hold the role of Director in CMC since January 2023.

Ilia Terova completed a Bachelor of Science degree in Chemistry from Worcester State University between 1998 and 2002. They then pursued a Doctor of Philosophy (Ph.D.) degree in Analytical Chemistry at the University of New Hampshire from 2004 to 2010.